Lifevantage EBITDA Margin 2012-2026 | LFVN
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Lifevantage (LFVN) over the last 10 years. The current EBITDA margin for Lifevantage as of June 30, 2026 is .
| Lifevantage EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2026-06-30 | $0.18B | $0.01B | 4.37% |
| 2026-03-31 | $0.20B | $0.01B | 4.59% |
| 2025-12-31 | $0.21B | $0.01B | 5.71% |
| 2025-09-30 | $0.23B | $0.02B | 6.55% |
| 2025-06-30 | $0.23B | $0.02B | 6.58% |
| 2025-03-31 | $0.22B | $0.02B | 7.21% |
| 2024-12-31 | $0.21B | $0.01B | 6.60% |
| 2024-09-30 | $0.20B | $0.01B | 5.10% |
| 2024-06-30 | $0.20B | $0.01B | 4.50% |
| 2024-03-31 | $0.21B | $0.01B | 4.39% |
| 2023-12-31 | $0.21B | $0.01B | 3.79% |
| 2023-09-30 | $0.21B | $0.01B | 3.76% |
| 2023-06-30 | $0.21B | $0.01B | 3.74% |
| 2023-03-31 | $0.21B | $0.01B | 2.37% |
| 2022-12-31 | $0.21B | $0.01B | 2.90% |
| 2022-09-30 | $0.21B | $0.01B | 3.41% |
| 2022-06-30 | $0.21B | $0.01B | 5.34% |
| 2022-03-31 | $0.21B | $0.02B | 8.57% |
| 2021-12-31 | $0.21B | $0.02B | 8.49% |
| 2021-09-30 | $0.22B | $0.02B | 10.96% |
| 2021-06-30 | $0.22B | $0.02B | 10.86% |
| 2021-03-31 | $0.23B | $0.02B | 10.67% |
| 2020-12-31 | $0.23B | $0.03B | 10.92% |
| 2020-09-30 | $0.23B | $0.02B | 9.96% |
| 2020-06-30 | $0.23B | $0.02B | 9.05% |
| 2020-03-31 | $0.23B | $0.02B | 8.30% |
| 2019-12-31 | $0.23B | $0.02B | 7.86% |
| 2019-09-30 | $0.23B | $0.01B | 6.19% |
| 2019-06-30 | $0.23B | $0.01B | 5.31% |
| 2019-03-31 | $0.22B | $0.01B | 4.91% |
| 2018-12-31 | $0.22B | $0.01B | 5.02% |
| 2018-09-30 | $0.21B | $0.01B | 6.19% |
| 2018-06-30 | $0.20B | $0.01B | 6.40% |
| 2018-03-31 | $0.20B | $0.01B | 5.00% |
| 2017-12-31 | $0.19B | $0.01B | 4.12% |
| 2017-09-30 | $0.19B | $0.01B | 3.09% |
| 2017-06-30 | $0.20B | $0.01B | 3.00% |
| 2017-03-31 | $0.20B | $0.01B | 4.46% |
| 2016-12-31 | $0.21B | $0.01B | 5.63% |
| 2016-09-30 | $0.22B | $0.02B | 6.94% |
| 2016-06-30 | $0.21B | $0.02B | 7.77% |
| 2016-03-31 | $0.20B | $0.01B | 6.57% |
| 2015-12-31 | $0.19B | $0.01B | 5.88% |
| 2015-09-30 | $0.18B | $0.01B | 6.01% |
| 2015-06-30 | $0.19B | $0.02B | 8.42% |
| 2015-03-31 | $0.20B | $0.02B | 9.45% |
| 2014-12-31 | $0.21B | $0.02B | 10.43% |
| 2014-09-30 | $0.22B | $0.02B | 11.16% |
| 2014-06-30 | $0.21B | $0.02B | 10.28% |
| 2014-03-31 | $0.21B | $0.02B | 8.57% |
| 2013-12-31 | $0.21B | $0.02B | 8.29% |
| 2013-09-30 | $0.21B | $0.01B | 5.83% |
| 2013-06-30 | $0.21B | $0.01B | 6.25% |
| 2013-03-31 | $0.20B | $0.02B | 9.95% |
| 2012-12-31 | $0.19B | $0.02B | 12.30% |
| 2012-09-30 | $0.16B | $0.03B | 16.35% |
| 2012-06-30 | $0.13B | $0.02B | 18.25% |
| 2012-03-31 | $0.10B | $0.02B | 17.71% |
| 2011-12-31 | $0.07B | $0.01B | 12.86% |
| 2011-09-30 | $0.05B | $0.01B | 13.46% |
| 2011-06-30 | $0.04B | $0.00B | 7.89% |
| 2011-03-31 | $0.03B | 0 | 0.00% |
| 2010-12-31 | $0.02B | 0 | 0.00% |
| 2010-09-30 | $0.02B | $0.00B | -26.67% |
| 2010-06-30 | $0.01B | $-0.01B | -63.64% |
| 2010-03-31 | $0.01B | $-0.01B | -122.22% |
| 2009-12-31 | $0.01B | $-0.01B | -171.43% |
| 2009-09-30 | $0.01B | $-0.01B | -166.67% |
| 2009-06-30 | $0.01B | $-0.01B | -140.00% |
| 2009-03-31 | $0.00B | $0.00B | -75.00% |
| 2008-12-31 | $0.00B | $0.00B | -25.00% |
| 2008-09-30 | $0.00B | $0.00B | -25.00% |
| 2008-06-30 | $0.00B | $0.00B | -25.00% |
| 2008-03-31 | $0.00B | $0.00B | -25.00% |
| 2007-12-31 | $0.00B | $0.00B | -50.00% |
| 2007-09-30 | $0.00B | $0.00B | -100.00% |
| 2007-06-30 | $0.01B | $-0.01B | -100.00% |
| 2007-03-31 | $0.01B | $-0.01B | -120.00% |
| 2006-12-31 | $0.01B | $-0.01B | -120.00% |
| 2006-09-30 | $0.01B | $-0.01B | -83.33% |
| 2006-06-30 | $0.01B | $0.00B | -57.14% |
| 2006-03-31 | $0.01B | 0 | 0.00% |
| 2005-12-31 | $0.01B | $0.00B | 14.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.077B | $0.183B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |